BCR-ABL tyrosine kinase inhibitor (TKI)-induced nephropathy: An under-recognized phenomenon Journal Article

   

Authors:	Stanchina, M.; McKinnell, Z.; Park, J. H.; Stein, E. M.; Cai, S. F.; Taylor, J.
Article Title:	BCR-ABL tyrosine kinase inhibitor (TKI)-induced nephropathy: An under-recognized phenomenon
Keywords:	adult; clinical article; human tissue; middle aged; case report; drug dose reduction; drug withdrawal; hypertension; cytarabine; drug megadose; imatinib; edema; multiple cycle treatment; skin biopsy; cell infiltration; kidney disease; thrombocytopenia; inflammation; creatinine; dasatinib; chronic myeloid leukemia; acute lymphoblastic leukemia; protein tyrosine kinase inhibitor; fever; rash; acute kidney failure; mononuclear cell; kidney function; mitoxantrone; allogeneic hematopoietic stem cell transplantation; pleura effusion; lactate dehydrogenase; drug dose increase; nilotinib; drug substitution; hemolytic uremic syndrome; haptoglobin; cholecystitis; kidney biopsy; proteinuria; thrombotic thrombocytopenic purpura; bcr-abl; allopurinol; blinatumomab; ponatinib; human; male; female; priority journal; article; lower limb
Journal Title:	Leukemia Research Reports
Volume:	14
ISSN:	2213-0489
Publisher:	Elsevier Inc.
Date Published:	2020-01-01
Start Page:	100211
Language:	English
DOI:	10.1016/j.lrr.2020.100211
PROVIDER:	scopus
PMCID:	PMC7327424
PUBMED:	32637309
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85086869095&doi=10.1016%2fj.lrr.2020.100211&partnerID=40&md5=afba8ff58422a92f6b23f77effd74bd6
Notes:	Article -- Export Date: 3 August 2020 -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/168465